• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.无症状高危家族成员前瞻性研究中多发性硬化早期证据的评估。
JAMA Neurol. 2017 Mar 1;74(3):293-300. doi: 10.1001/jamaneurol.2016.5056.
2
Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.慢性活动性多发性硬化症病灶与体内残疾的关联。
JAMA Neurol. 2019 Dec 1;76(12):1474-1483. doi: 10.1001/jamaneurol.2019.2399.
3
Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.中央静脉征作为多发性硬化症诊断影像学生物标志物的评估。
JAMA Neurol. 2019 Dec 1;76(12):1446-1456. doi: 10.1001/jamaneurol.2019.2478.
4
Conversion of clinically isolated syndrome to multiple sclerosis: a prospective study.临床孤立综合征向多发性硬化症的转化:一项前瞻性研究。
Mult Scler Relat Disord. 2020 Sep;44:102262. doi: 10.1016/j.msard.2020.102262. Epub 2020 Jun 4.
5
Clinical and diagnostic features of patients with familial multiple sclerosis.家族性多发性硬化症患者的临床和诊断特征。
Med Hypotheses. 2019 Oct;131:109310. doi: 10.1016/j.mehy.2019.109310. Epub 2019 Jul 13.
6
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.识别多发性硬化症中的独特认知表型。
JAMA Neurol. 2021 Apr 1;78(4):414-425. doi: 10.1001/jamaneurol.2020.4920.
7
Associations Between Findings From Myelin Water Imaging and Cognitive Performance Among Individuals With Multiple Sclerosis.多发性硬化症患者脑内髓鞘水成像表现与认知功能的相关性研究
JAMA Netw Open. 2020 Sep 1;3(9):e2014220. doi: 10.1001/jamanetworkopen.2020.14220.
8
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.采用 2016 年 MAGNIMS 和 2010 年 McDonald 标准预测临床孤立综合征患者的多发性硬化症诊断:一项回顾性研究。
Lancet Neurol. 2018 Feb;17(2):133-142. doi: 10.1016/S1474-4422(17)30469-6. Epub 2017 Dec 21.
9
Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.HLA 遗传风险负担与多发性硬化症疾病表型的关联。
JAMA Neurol. 2016 Jul 1;73(7):795-802. doi: 10.1001/jamaneurol.2016.0980.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
The 2024 revisions of the McDonald criteria pose risk of multiple sclerosis overdiagnosis.2024年修订的麦克唐纳标准存在多发性硬化症过度诊断的风险。
Nat Rev Neurol. 2025 Sep 17. doi: 10.1038/s41582-025-01140-4.
2
Phenotyping Healthcare Use 2-3 Decades Before the First Multiple Sclerosis Demyelinating Event.在首次多发性硬化脱髓鞘事件发生前20至30年的医疗保健使用情况表型分析。
Ann Clin Transl Neurol. 2025 Aug;12(8):1585-1594. doi: 10.1002/acn3.70092. Epub 2025 Jun 12.
3
The refined Pathways to Cures Research Roadmap for multiple sclerosis cures.多发性硬化症治愈的精细化途径研究路线图。
Mult Scler. 2024 Sep;30(10):1242-1251. doi: 10.1177/13524585241266483. Epub 2024 Aug 30.
4
Modulation of multiple sclerosis risk and pathogenesis by the gut microbiota: Complex interactions between host genetics, bacterial metabolism, and diet.肠道微生物群对多发性硬化症风险和发病机制的调节:宿主遗传学、细菌代谢和饮食之间的复杂相互作用。
Immunol Rev. 2024 Aug;325(1):131-151. doi: 10.1111/imr.13343. Epub 2024 May 8.
5
Impact of the COVID-19 Pandemic on the Personal Networks and Neurological Outcomes of People With Multiple Sclerosis: Cross-Sectional and Longitudinal Case-Control Study.2019年冠状病毒病大流行对多发性硬化症患者个人社交网络和神经学结局的影响:横断面和纵向病例对照研究
JMIR Public Health Surveill. 2024 Feb 6;10:e45429. doi: 10.2196/45429.
6
Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort.在密歇根州一个新的病例/对照队列中,持久性有机污染物的环境风险评分与肌萎缩侧索硬化症(ALS)的较高风险及较短生存期相关。
J Neurol Neurosurg Psychiatry. 2024 Feb 14;95(3):241-248. doi: 10.1136/jnnp-2023-332121.
7
Differential impact of environmental factors on systemic and localized autoimmunity.环境因素对系统性和局部自身免疫的影响差异。
Front Immunol. 2023 May 22;14:1147447. doi: 10.3389/fimmu.2023.1147447. eCollection 2023.
8
Fitts' Tapping Task as a New Test for Cognition and Manual Dexterity in Multiple Sclerosis: Validation Study.Fitts' 敲击任务作为多发性硬化症认知和手动灵巧性的新测试:验证研究。
Medicina (Kaunas). 2022 Dec 23;59(1):29. doi: 10.3390/medicina59010029.
9
Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis.血清神经丝轻链作为多发性硬化症疾病活动预后生物标志物的有效性。
J Neurol. 2023 Apr;270(4):1908-1930. doi: 10.1007/s00415-022-11507-y. Epub 2022 Dec 15.
10
Investigating the role of common and rare variants in multiplex multiple sclerosis families reveals an increased burden of common risk variation.研究多发性硬化症家系中常见和罕见变异的作用揭示了常见风险变异的负担增加。
Sci Rep. 2022 Oct 10;12(1):16984. doi: 10.1038/s41598-022-21484-x.

本文引用的文献

1
Validity of the Timed Up and Go Test as a Measure of Functional Mobility in Persons With Multiple Sclerosis.定时起立行走测试作为多发性硬化症患者功能活动能力衡量指标的有效性。
Arch Phys Med Rehabil. 2016 Jul;97(7):1072-7. doi: 10.1016/j.apmr.2015.12.031. Epub 2016 Mar 2.
2
"Central vessel sign" on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine.3T FLAIR* MRI 上的“中央血管征”在鉴别多发性硬化与偏头痛中的作用。
Ann Clin Transl Neurol. 2015 Dec 16;3(2):82-7. doi: 10.1002/acn3.273. eCollection 2016 Feb.
3
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.多发性硬化诊断的MRI标准:MAGNIMS共识指南。
Lancet Neurol. 2016 Mar;15(3):292-303. doi: 10.1016/S1474-4422(15)00393-2. Epub 2016 Jan 26.
4
Genes and Environment in Multiple Sclerosis project: A platform to investigate multiple sclerosis risk.多发性硬化症中的基因与环境项目:一个研究多发性硬化症风险的平台。
Ann Neurol. 2016 Feb;79(2):178-89. doi: 10.1002/ana.24560. Epub 2015 Dec 9.
5
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.基于钆的磁共振成像对多发性硬化软脑膜炎症的特征分析
Neurology. 2015 Jul 7;85(1):18-28. doi: 10.1212/WNL.0000000000001587. Epub 2015 Apr 17.
6
Longitudinal relationships among posturography and gait measures in multiple sclerosis.多发性硬化症中姿势描记法与步态测量之间的纵向关系。
Neurology. 2015 May 19;84(20):2048-56. doi: 10.1212/WNL.0000000000001580. Epub 2015 Apr 15.
7
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses.环境风险因素与多发性硬化症:系统评价和荟萃分析的伞状综述。
Lancet Neurol. 2015 Mar;14(3):263-73. doi: 10.1016/S1474-4422(14)70267-4. Epub 2015 Feb 4.
8
The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis.符号数字模态测验作为多发性硬化症认知障碍的哨兵测试。
Eur J Neurol. 2014 Sep;21(9):1219-25, e71-2. doi: 10.1111/ene.12463. Epub 2014 May 22.
9
The impact of dynamic balance measures on walking performance in multiple sclerosis.动态平衡测量对多发性硬化症患者步行能力的影响。
Neurorehabil Neural Repair. 2015 Jan;29(1):62-9. doi: 10.1177/1545968314532835. Epub 2014 May 1.
10
Radiologically isolated syndrome: 5-year risk for an initial clinical event.影像学孤立综合征:首次临床事件的5年风险
PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

无症状高危家族成员前瞻性研究中多发性硬化早期证据的评估。

Assessment of Early Evidence of Multiple Sclerosis in a Prospective Study of Asymptomatic High-Risk Family Members.

机构信息

Program in Translational Neuropsychiatric Genomics and Partners Multiple Sclerosis Center, Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts2Harvard Medical School, Boston, Massachusetts3Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts4Program in Translational Neurology and Neuroinflammation, Pittsburgh Institute of Neurodegenerative Diseases and Institute of Multiple Sclerosis Care and Research, Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania.

Division of Neuroimmunology and Neurovirology, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland.

出版信息

JAMA Neurol. 2017 Mar 1;74(3):293-300. doi: 10.1001/jamaneurol.2016.5056.

DOI:10.1001/jamaneurol.2016.5056
PMID:28114441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5348267/
Abstract

IMPORTANCE

Subclinical inflammatory demyelination and neurodegeneration often precede symptom onset in multiple sclerosis (MS).

OBJECTIVE

To investigate the prevalence of brain magnetic resonance imaging (MRI) and subclinical abnormalities among asymptomatic individuals at risk for MS.

DESIGN, SETTING, AND PARTICIPANTS: The Genes and Environment in Multiple Sclerosis (GEMS) project is a prospective cohort study of first-degree relatives of people with MS. Each participant's risk for MS was assessed using a weighted score (Genetic and Environmental Risk Score for Multiple Sclerosis Susceptibility [GERSMS]) comprising an individual's genetic burden and environmental exposures. The study dates were August 2012 to July 2015.

MAIN OUTCOMES AND MEASURES

Participants in the top and bottom 10% of the risk distribution underwent standard and quantitative neurological examination, including disability status, visual, cognitive, motor, and sensory testing, as well as qualitative and quantitative neuroimaging with 3-T brain MRI and optical coherence tomography.

RESULTS

This study included 100 participants at risk for MS, with 41 at higher risk (40 women [98%]) and 59 at lower risk (25 women [42%]), at a mean (SD) age of 35.1 (8.7) years. Given the unequal sex distribution between the 2 groups, the analyses were restricted to women (n = 65). When considering all measured outcomes, higher-risk women differed from lower-risk women (P = .01 by omnibus test). Detailed testing with a vibration sensitivity testing device in a subgroup of 47 women showed that higher-risk women exhibited significantly poorer vibration perception in the distal lower extremities (P = .008, adjusting for age, height, and testing date). Furthermore, 5 of 65 women (8%) (4 at higher risk and 1 at lower risk) met the primary neuroimaging outcome of having T2-weighted hyperintense brain lesions consistent with the 2010 McDonald MRI criteria for dissemination in space. A subset of participants harbor many different neuroimaging features associated with MS, including perivenous T2-weighted hyperintense lesions and focal leptomeningeal enhancement, consistent with the hypothesis that these individuals are at higher risk of developing clinical symptoms of MS than the general population.

CONCLUSIONS AND RELEVANCE

Higher-risk asymptomatic family members of patients with MS are more likely to have early subclinical manifestations of MS. These findings underscore the importance of early detection in high-risk individuals.

TRIAL REGISTRATION

clinicaltrials.gov Identifier: NCT01353547.

摘要

重要性

在多发性硬化症(MS)中,亚临床炎症性脱髓鞘和神经退行性变通常先于症状出现。

目的

研究有 MS 风险的无症状个体中脑磁共振成像(MRI)和亚临床异常的患病率。

设计、设置和参与者:多发性硬化症的基因和环境(GEMS)项目是一项对 MS 患者一级亲属的前瞻性队列研究。每位参与者的 MS 风险均使用加权评分(多发性硬化症易感性的遗传和环境风险评分 [GERSMS])进行评估,该评分包括个体的遗传负担和环境暴露。研究日期为 2012 年 8 月至 2015 年 7 月。

主要结果和测量

风险分布前 10%和后 10%的参与者接受了标准和定量神经检查,包括残疾状况、视觉、认知、运动和感觉测试,以及使用 3-T 脑部 MRI 和光学相干断层扫描进行定性和定量神经影像学检查。

结果

这项研究包括 100 名有 MS 风险的参与者,其中 41 名处于高风险(40 名女性[98%]),59 名处于低风险(25 名女性[42%]),平均(SD)年龄为 35.1(8.7)岁。由于两组之间的性别分布不均,因此分析仅限于女性(n=65)。考虑到所有测量结果,高风险女性与低风险女性不同(通过总检验 P=0.01)。在 47 名女性的亚组中使用振动敏感测试设备进行详细测试表明,高风险女性在下肢远端的振动感知明显较差(P=0.008,调整年龄、身高和测试日期)。此外,65 名女性中有 5 名(8%)(4 名高风险,1 名低风险)符合 2010 年 McDonald MRI 标准的 T2 加权高信号脑病变,提示这些女性发生 MS 临床症状的风险高于一般人群。亚组的一部分参与者具有许多与 MS 相关的不同神经影像学特征,包括静脉周围 T2 加权高信号病变和局灶性软脑膜强化,这与假设这些个体比一般人群更容易出现 MS 的临床症状一致。

结论和相关性

MS 患者的高风险无症状家庭成员更有可能出现 MS 的早期亚临床表现。这些发现强调了在高危个体中进行早期检测的重要性。

试验注册

clinicaltrials.gov 标识符:NCT01353547。